SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
Over last decade, a substantial progress has been made, with respect to understanding of cancer biology and its interplay with the host immune system. Different immunotherapeutic drugs based on recombinant cytokines and monoclonal antibodies are widely used in cancer therapy, and a large number of e...
Saved in:
Main Authors: | T. S. Nepomnyashchikh, D. V. Antonets, R. A. Maksyutov |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/2b2e74cb209d4fa0b24f5f2f85dca31b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obtainingvaccinia virus with increased production of extracellular enveloped virions and directing GM-CSF synthesis as a promising basis for development of antitumor drug
by: T. V. Bauer, et al.
Published: (2020) -
Viruses as nanomedicine for cancer
by: Badrinath N, et al.
Published: (2016) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
by: Kyle M. Pierce, et al.
Published: (2021) -
SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
by: T. S. Nepomnyashchikh, et al.
Published: (2019) -
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
by: Alireza Rajabzadeh, et al.
Published: (2021)